• LAST PRICE
    0.8121
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    0.7933/ 1
  • Ask / Lots
    0.8200/ 10
  • Open / Previous Close
    0.7971 / 0.8121
  • Day Range
    Low 0.7910
    High 0.8281
  • 52 Week Range
    Low 0.4803
    High 1.5200
  • Volume
    308,301
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Monday's close: 0.79
TimeVolumeSEEL
09:32 ET91030.8123
09:33 ET7000.797201
09:35 ET7210.8047
09:39 ET1850.8001
09:42 ET109920.791
09:44 ET1000.791
09:55 ET5000.7968
09:57 ET2500.8025
10:00 ET23000.7926
10:02 ET19500.792
10:06 ET15000.8025
10:08 ET7000.792
10:09 ET1000.8025
10:11 ET8000.7921
10:13 ET56000.7984
10:22 ET76420.8046
10:24 ET1000.8042
10:27 ET46020.8049
10:29 ET5000.8051
10:31 ET160900.8179
10:33 ET2000.82
10:40 ET1000.81
10:44 ET2500.8281
10:45 ET1000.8
10:47 ET8000.82
10:49 ET5000.8201
10:51 ET26960.82
10:54 ET13000.8002
10:58 ET3010.8002
11:00 ET1000.8
11:02 ET1000.8
11:05 ET1000.8
11:07 ET1000.8
11:09 ET1000.82
11:12 ET14000.82
11:14 ET1000.8
11:16 ET1000.82
11:20 ET2000.82
11:23 ET2000.8001
11:25 ET1000.8
11:27 ET1000.815
11:30 ET2000.815
11:36 ET39000.8019
11:41 ET1000.8007
11:45 ET2500.8007
11:48 ET29600.8
11:50 ET23000.8
11:52 ET1000.8
11:56 ET1000.818
11:59 ET2000.818
12:03 ET3000.8101
12:08 ET10010.8101
12:12 ET2790.8167
12:14 ET1000.8101
12:15 ET10000.8101
12:17 ET1000.8101
12:19 ET204000.8101
12:21 ET5000.8101
12:24 ET1000.8101
12:26 ET6000.8101
12:30 ET20550.8101
12:33 ET4000.8101
12:35 ET2000.8148
12:39 ET1000.8124
12:46 ET14650.810635
12:48 ET2000.8101
12:50 ET2000.8101
12:51 ET4150.8147
12:55 ET5000.8101
12:57 ET16060.808301
01:00 ET2240.8115
01:06 ET2390.8101
01:08 ET1000.8101
01:11 ET2000.81
01:13 ET2000.8145
01:18 ET2000.8145
01:20 ET1000.8125
01:22 ET1000.8125
01:24 ET10000.81
01:26 ET1000.8097
01:27 ET1000.8095
01:29 ET13000.8044
01:31 ET1000.8097
01:36 ET4150.815
01:38 ET5480.8101
01:40 ET1000.8101
01:42 ET5330.815
01:44 ET15240.819
01:45 ET1000.819
01:47 ET1000.8051
01:49 ET3000.8118
01:54 ET103990.8058
01:56 ET6190.8
02:00 ET13820.8
02:03 ET109370.8103
02:09 ET3430.8102
02:12 ET125720.796
02:14 ET4000.796
02:16 ET25000.804
02:18 ET7620.8096
02:21 ET1000.8096
02:23 ET75000.805
02:25 ET10790.805
02:27 ET2000.819
02:30 ET2000.805
02:32 ET11000.8186
02:36 ET2000.819
02:38 ET7000.805
02:39 ET18000.8121
02:41 ET1000.8182
02:43 ET1000.8146
02:45 ET5000.8146
02:48 ET1000.8157
02:50 ET17000.8155
02:52 ET1000.8146
02:56 ET7800.8175
02:57 ET1000.8146
02:59 ET12150.819
03:01 ET14730.81899
03:03 ET1000.819
03:06 ET6120.817908
03:10 ET18860.819
03:12 ET6760.8103
03:14 ET356100.8
03:17 ET6000.8197
03:19 ET1000.8099
03:21 ET5000.8099
03:24 ET1580.8099
03:26 ET3000.80995
03:28 ET5000.8198
03:30 ET1000.8101
03:32 ET2000.8198
03:35 ET8390.8158
03:37 ET15130.812
03:39 ET6470.8119
03:42 ET1000.8101
03:44 ET16310.8193
03:46 ET10290.8119
03:48 ET7990.81
03:50 ET4000.8
03:51 ET4830.8186
03:53 ET13470.8119
03:55 ET384490.816
03:57 ET18020.8161
04:00 ET7000.8121
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesSEEL
Seelos Therapeutics Inc
87.0M
-1.0x
---
United StatesBGXX
Bright Green Corp
88.5M
-3.2x
---
United StatesOCUP
Ocuphire Pharma Inc
72.2M
-3.0x
---
United StatesIMAB
I-Mab
500.3M
-1.4x
---
United StatesORTX
Orchard Therapeutics PLC
70.5M
-0.4x
---
United StatesPMCB
PharmaCyte Biotech Inc
54.1M
-10.7x
---
As of 2023-02-01

Company Information

Seelos Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development of products that address unmet needs in central nervous system (CNS) disorders and other rare disorders. The Company's lead programs SLS-002 for the treatment of acute suicidal ideation and behavior (ASIB) in depressive disorder (MDD), and SLS-005 for the potential treatment of amyotrophic lateral sclerosis (ALS). SLS-005 for the potential treatment of Sanfilippo Syndromes, which is being explored. It is also developing several preclinical programs, including SLS-010, an oral histamine H3A receptor antagonist that shows promising activity in narcolepsy and related disorders, and SLS-012, an injectable therapy for post-operative pain management. The Company's ongoing programs include SLS-004, SLS-006, SLS-007 and SLS-008.

Contact Information

Headquarters
300 PARK AVENUE, 2ND FLOORNEW YORK, NY, United States 10022
Phone
646-293-2100
Fax
858-436-8155

Executives

Chairman of the Board, President, Chief Executive Officer
Raj Mehra
Chief Financial Officer
Michael Golembiewski
Director
Daniel O'Connor
Independent Director
Margaret Dalesandro
Independent Director
Brian Lian

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$87.0M
Revenue (TTM)
$0.00
Shares Outstanding
107.2M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
2.03
EPS
$-0.78
Book Value
$0.54
P/E Ratio
-1.0x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.